Global Information
회사소개 | 문의 | 비교리스트

신생항원 시장 예측(-2028년) : COVID-19의 영향과 세계 시장 분석

Neoantigens Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment and Therapeutic Specialty

리서치사 The Insight Partners
발행일 2021년 05월 상품코드 1015795
페이지 정보 영문 151 Pages 배송안내
가격
US $ 4,550 ₩ 6,463,000 PDF (Single User License)
US $ 6,550 ₩ 9,304,000 PDF (Site License)
US $ 8,550 ₩ 12,146,000 PDF (Enterprise License)


신생항원 시장 예측(-2028년) : COVID-19의 영향과 세계 시장 분석 Neoantigens Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment and Therapeutic Specialty
발행일 : 2021년 05월 페이지 정보 : 영문 151 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 신생항원 시장은 2020년 2억 7,142만 8,570달러에서 2028년까지 10억 5,478만 3,540달러에 달하고, 2020-2028년 CAGR로 18.49%의 성장이 예측됩니다.

세계의 신생항원(Neoantigens) 시장에 대해 조사 분석했으며, 시장 상황, 시장 역학, 부문별 시장 분석, 지역별 시장 분석, 경쟁 상황, 주요 기업에 대한 체계적인 정보를 제공합니다.

목차

제1장 서론

제2장 신생항원 시장 : 요점

제3장 조사 방법

제4장 신생항원 시장 : 시장 상황

  • 개요
  • PEST 분석
  • 전문가의 견해

제5장 신생항원 시장 : 주요 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 영향 분석

제6장 신생항원 시장 : 세계의 분석

  • 세계의 신생항원 시장 매출 예측과 분석
  • 세계의 신생항원 시장 : 지역별 - 예측과 분석
  • 주요 기업

제7장 신생항원 시장 분석 : 치료별

  • 개요
  • 신생항원 시장 매출 점유율 : 치료별
  • 병용요법
  • 단독요법

제8장 신생항원 시장 분석 : 전문 치료별

  • 개요
  • 신생항원 시장 매출 점유율 : 전문 치료별
  • 소화기암
  • 폐암
  • 고형 종양
  • 비뇨기계암
  • 흑색종
  • 두경부암
  • 기타

제9장 신생항원 시장 : 지역별 분석

  • 북미 : 신생항원 시장 매출과 예측
  • 유럽 : 신생항원 시장
  • 아시아태평양 : 신생항원 시장
  • 중동 및 아프리카 : 신생항원 시장
  • 중남미 : 신생항원 시장

제10장 세계의 신생항원 시장에 대한 COVID-19의 영향

  • 북미 : COVID-19 팬데믹의 영향 평가
  • 유럽 : COVID-19 팬데믹의 영향 평가
  • 아시아태평양 : COVID-19 팬데믹의 영향 평가
  • 중동 및 아프리카 : COVID-19 팬데믹의 영향 평가
  • 중남미 : COVID-19 팬데믹의 영향 평가

제11장 신생항원 시장 : 업계 상황

제12장 기업 개요

  • Achilles Therapeutics plc
  • Advaxis, Inc.
  • Frame Cancer Therapeutics
  • Genocea
  • Gradalis, Inc.
  • Gritstone Oncology
  • Immunicum AB
  • Medigene AG
  • Ziopharm Oncology, Inc.
  • Moderna, Inc.

제13장 부록

KSM 21.07.20

List Of Tables

  • Table 1. New Cancer Cases Registered Worldwide, 2020
  • Table 2. North America: Neoantigens Market, by Treatment - Revenue and Forecast to 2028(USD Thousand)
  • Table 3. North America: Neoantigens Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 4. US: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 5. US: Neoantigens Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 6. Canada: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 7. Canada: Neoantigens Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 8. Mexico: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 9. Mexico: Neoantigens Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 10. Europe: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 11. Europe: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 12. Incidence, Mortality and Prevalence by cancer site, 2020, Germany
  • Table 13. Germany: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 14. Germany: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 15. Incidence, Mortality and Prevalence by cancer site, 2020, France
  • Table 16. France: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 17. France: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 18. UK: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 19. UK: Neoantigens Market, Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 20. Incidence, Mortality and Prevalence by cancer site, 2020, Italy
  • Table 21. Italy: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 22. Italy: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 23. Incidence, Mortality and Prevalence by cancer site, 2020, Spain
  • Table 24. Spain: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 25. Spain: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 26. Rest of Europe: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 27. Rest of Europe: Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 28. Asia Pacific Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 29. Asia Pacific Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 30. China Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 31. China Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 32. Japan Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 33. Japan Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 34. India Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 35. India Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 36. South Korea Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 37. South Korea Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 38. Incidence, Mortality and Prevalence by Cancer Site, Australia, 2020
  • Table 39. Australia Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 40. Australia Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 41. Rest of Asia-Pacific: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 42. Rest of Asia-Pacific: Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 43. Middle East and Africa Neoantigens Market, by Treatment- Revenue and Forecast to 2028(USD Thousand)
  • Table 44. Middle East and Africa Equipment Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 45. UAE Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 46. UAE Equipment Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 47. Saudi Arabia Neoantigens Market, by Treatment- Revenue and Forecast to 2028 (USD Thousand)
  • Table 48. Saudi Arabia Equipment Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 49. South Africa Neoantigens Market, by Treatment- Revenue and Forecast to 2028 (USD Thousand)
  • Table 50. South Africa Neoantigens Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 51. Rest of Middle East and Africa Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 52. Rest of Middle East and Africa Neoantigens Market, by Therapeutic Specialty - Revenue and Forecast to 2028 (USD Thousand)
  • Table 53. South and Central America Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 54. South and Central America Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 55. Brazil Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 56. Brazil Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 57. Argentina Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 58. Argentina Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 59. Rest of South and Central America Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
  • Table 60. Rest of South and Central America Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • Table 61. Glossary of Terms, Neoantigens Market

List Of Figures

  • Figure 1. Neoantigens Market Segmentation
  • Figure 2. Neoantigens Segmentation, By Region
  • Figure 3. Global Neoantigens Market Overview
  • Figure 4. Combination Therapy Segment Holds Largest Share of Neoantigens Market
  • Figure 5. APAC to Show Remarkable Growth During Forecast Period
  • Figure 6. Global Neoantigens Market, by Geography (US$ Thousand)
  • Figure 7. Global Neoantigens Market - Leading Country Markets (US$ Thousand)
  • Figure 8. Global Neoantigens Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Expert Opinion
  • Figure 15. Neoantigens Market Impact Analysis of Drivers and Restraints
  • Figure 16. Global Neoantigens Market - Revenue Forecast and Analysis - 2023- 2028
  • Figure 17. Global Neoantigens Market - By Geography Forecast and Analysis - 2020- 2028
  • Figure 18. Neoantigens Market Revenue Share, by Treatment (2023 and 2028)
  • Figure 19. Combination Therapy: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 20. Mono Therapy: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 21. Neoantigens Market Revenue Share, by Therapeutic Specialty (2023 and 2028)
  • Figure 22. Gastrointestinal Cancer: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 23. Lung Cancer: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 24. Solid Tumors: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 25. Urinary System Cancers: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 26. Melanoma: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 27. Head and Neck Cancers: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 28. Others: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 29. North America: Neoantigens Market, by Key Country - Revenue (2023) (USD Thousand)
  • Figure 30. North America: Neoantigens Market Revenue and Forecast to 2028 (USD Thousand)
  • Figure 31. North America: Neoantigens Market, by Country, 2023 & 2028 (%)
  • Figure 32. US: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 33. Canada: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 34. Mexico: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 35. Europe: Neoantigens Market, by Key Country - Revenue (2023) (USD Thousand)
  • Figure 36. Europe: Neoantigens Market Revenue and Forecast to 2028 (USD Thousand)
  • Figure 37. Europe: Neoantigens Market, by Country, 2023 & 2028 (%)
  • Figure 38. Germany: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 39. France: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 40. UK: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 41. Italy: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 42. Spain: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 43. Rest of Europe: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 44. Asia Pacific: Neoantigens Market, by Key Country - Revenue (2023) (USD Thousand)
  • Figure 45. Asia Pacific Neoantigens Market Revenue and Forecast to 2028 (USD Thousand)
  • Figure 46. Asia Pacific: Neoantigens Market, by Country, 2023 & 2028 (%)
  • Figure 47. China: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 48. Japan: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 49. India: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 50. South Korea: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 51. Australia: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 52. Rest of Asia-Pacific: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 53. Middle East and Africa: Neoantigens Market, by Key Country - Revenue (2023) (USD Thousand)
  • Figure 54. Middle East and Africa Neoantigens Market Revenue and Forecast to 2028 (USD Thousand)
  • Figure 55. UAE: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 56. Saudi Arabia: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 57. South Africa: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 58. Rest of Middle East and Africa: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 59. South and Central America: Neoantigens Market, by Key Country - Revenue (2023) (USD Thousand)
  • Figure 60. South and Central America: Neoantigens Market, by Country, 2023 & 2028 (%)
  • Figure 61. South and Central America: Neoantigens Market, by Country, 2023 & 2028 (%)
  • Figure 62. Brazil: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 63. Argentina: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 64. Rest of South and Central America: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
  • Figure 65. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 66. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 67. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 68. Impact Of COVID-19 Pandemic in Middle East and Africa Market
  • Figure 69. Impact Of COVID-19 Pandemic in South and Central America Market

The global neoantigens market is expected to reach US$ 10,54,783.54 thousand by 2028 from US$ 2,71,428.57 thousand in 2020. It is estimated to grow at a CAGR of 18.49% during 2020-2028.

Cancer has emerged as a leading cause of death worldwide. According to the World Health Organization (WHO), cancer was the first leading cause of death in the people of age below 70 years in 183 countries and fourth leading cause of death in 123 countries worldwide in 2019. In addition, according to data published by the WHO in March 2021, ~10 million deaths occurred in 2020 due to various cancer types; the list of new cancer cases registered in 2021 is provided below.

  • Table 1. New Cancer Cases Registered Worldwide, 2020

Sr. No. Cancer Type Cases Registered (Million)

1 Breast 2.26

2 Lung 2.21

3 Colon and Rectum 1.93

4 Prostate 1.41

5 Skin (Non-Melanoma) 1.20

6 Stomach 1.09

Source: WHO's cancer data for 2020

The increasing prevalence of cancer has created burden on the healthcare systems across the world. According to International Agency for Research on Cancer (IARC), the global burden of new cancer cases is estimated to reach ~ 27.5 million by 2040, and the disease likely to be a cause of ~163 million deaths by that year. Factors such as lifestyle changes, smoking, reduced physical activities, and uncertain health and climatic conditions are likely to lead to even greater burden of cancer in the world in the coming years. Therefore, it is essential to control and prevent the increasing number of cancers worldwide.

Various governments have initiated programs and initiative to increase the treatment and preventive measures for cancers. For instance, in 2017, World Health Assembly has approved the Resolution Cancer (WHA70.12), an integrated approach to prevent and control cancer. The program has been appealing the WHO and various governments to accelerate their efforts to achieve the targets that are specified in the Global Action Plan (2013-2020) for the prevention and control of noncommunicable diseases (NCDs) as well as in the 2030 UN Agenda for Sustainable Development to reduce early deaths from cancer. In addition, various private organizations have joined the action plans to prevent the increasing burden of cancer, which is creating a demand for better preventive measures against the disease. Thus, the increasing prevalence of cancer have accelerated the demand for new and effective therapeutic approaches such as neoantigens, which is boosting the growth of market.

Based on treatment, the neoantigens market is segmented into combination therapy and mono therapy. In 2023, the combination therapy segment is estimated to have a larger market share, whereas the mono therapy segment is expected to have a faster growth during the forecast period.

Based on therapeutic specialty, the neoantigens market is segmented into gastrointestinal cancer, lung cancer, solid tumor, urinary systems cancers, melanoma, head and neck cancer, and others. In 2023, the gastrointestinal cancer segment is estimated to hold the largest share of the market and is expected to grow at the fastest rate during the coming years.

Major primary and secondary sources referred to while preparing the report on the neoantigens market are American Association for Cancer Research, Cancer Association of South Africa, European Medicines Agency, The Food and Drug Administration, Institute for Research in Immunology and Cancer - Commercialization of Research, and the World Health Organization, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the neoantigens market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global neoantigens market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Neoantigens Market - By Treatment
    • 1.3.2 Neoantigens Market - By Therapeutic Specialty
    • 1.3.3 Neoantigens Market- By Geography

2. Neoantigens Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Neoantigens Market- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Neoantigens Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Developments in Neoantigen Vaccines Against Cancer
    • 5.1.2 Increasing Prevalence of Cancer
  • 5.2 Market Restraints
    • 5.2.1 Possible Side Effects Associated with Neoantigen Vaccines
  • 5.3 Market Opportunities
    • 5.3.1 Application of Next-generation Sequencing for Neoantigen Identification
  • 5.4 Future Trends
    • 5.4.1 Use of AI in Neoantigen Vaccine Development
  • 5.5 Impact Analysis

6. Neoantigens Market - Global Analysis

  • 6.1 Global Neoantigens Market Revenue Forecast and Analysis
  • 6.2 Global Neoantigens Market, By Geography - Forecast and Analysis
  • 6.3 Key Players

7. Neoantigens Market Analysis - By Treatment

  • 7.1 Overview
  • 7.2 Neoantigens Market Revenue Share, by Treatment (2023 and 2028)
  • 7.3 Combination Therapy
    • 7.3.1 Overview
    • 7.3.2 Combination Therapy: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 7.4 Mono Therapy
    • 7.4.1 Overview
    • 7.4.2 Mono Therapy: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)

8. Neoantigens Market Analysis - By Therapeutic Specialty

  • 8.1 Overview
  • 8.2 Neoantigens Market Revenue Share, by Therapeutic Specialty (2023 and 2028)
  • 8.3 Gastrointestinal Cancer
    • 8.3.1 Overview
    • 8.3.2 Gastrointestinal Cancer: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.4 Lung Cancer
    • 8.4.1 Overview
    • 8.4.2 Lung Cancer: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.5 Solid Tumors
    • 8.5.1 Overview
    • 8.5.2 Solid Tumors: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.6 Urinary System Cancers
    • 8.6.1 Overview
    • 8.6.2 Urinary System Cancers: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.7 Melanoma
    • 8.7.1 Overview
    • 8.7.2 Melanoma: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.8 Head and Neck Cancers
    • 8.8.1 Overview
    • 8.8.2 Head and Neck Cancers: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: Neoantigens Market- Revenue and Forecast to 2028 (US$ Thousand)

9. Neoantigens Market - Geographical Analysis

  • 9.1 North America: Neoantigens Market Revenue and Forecast to 2028
    • 9.1.1 Overview
    • 9.1.2 North America: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
    • 9.1.3 North America: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
    • 9.1.4 North America: Neoantigens Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
    • 9.1.5 North America: Neoantigens Market, by Country, 2023 & 2028 (%)
    • 9.1.6 US: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.1.6.1 US: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.1.6.2 US: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.1.6.3 US: Neoantigens Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
    • 9.1.7 Canada: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.1.7.1 Canada: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.1.7.2 Canada: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.1.7.3 Canada: Neoantigens Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
    • 9.1.8 Mexico: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.1.8.1 Mexico: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.1.8.2 Mexico: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.1.8.3 Mexico: Neoantigens Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
  • 9.2 Europe: Neoantigens Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
    • 9.2.3 Europe: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
    • 9.2.4 Europe: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
    • 9.2.5 Europe: Neoantigens Market, by Country, 2023 & 2028(%)
    • 9.2.6 Germany: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.6.1 Germany: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.6.2 Germany: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.6.3 Germany: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
    • 9.2.7 France: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.7.1 France: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.7.2 France: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.7.3 France: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
    • 9.2.8 UK: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.8.1 UK: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.8.2 UK: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.8.3 UK: Neoantigens Market, Application - Revenue and Forecast to 2028 (USD Thousand)
    • 9.2.9 Italy: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.9.1 Italy: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.9.2 Italy: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.9.3 Italy: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
    • 9.2.10 Spain: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.10.1 Spain: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.10.2 Spain: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.10.3 Spain: Neoantigens Market, Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
    • 9.2.11 Rest of Europe: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.11.1 Rest of Europe: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.11.2 Rest of Europe: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
      • 9.2.11.3 Rest of Europe: Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • 9.3 Asia Pacific: Neoantigens Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
    • 9.3.3 Asia Pacific: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
    • 9.3.4 Asia Pacific: Neoantigens Market, by Therapeutic Application - 2023-2028 (USD Thousand)
    • 9.3.5 Asia Pacific: Neoantigens Market, by Country, 2023 & 2028 (%)
    • 9.3.6 China: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.6.1 China: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.6.2 China: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.3.6.3 China: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)
    • 9.3.7 Japan: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.7.1 Japan: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.7.2 Japan: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.3.7.3 Japan: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)
    • 9.3.8 India: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.8.1 India: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.8.2 India: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.3.8.3 India: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)
    • 9.3.9 South Korea: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.9.1 South Korea: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.9.2 South Korea: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.3.9.3 South Korea: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)
    • 9.3.10 Australia: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.10.1 Australia: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.10.2 Australia: Neoantigens Market, by Treatment, 2019-2028 (USD Thousand)
      • 9.3.10.3 Australia: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)
    • 9.3.11 Rest of Asia-Pacific: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.11.1 Rest of Asia-Pacific: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.11.2 Rest of Asia-Pacific: Neoantigens Market, by Treatment - Revenue and Forecast to 2028 (USD Thousand)
      • 9.3.11.3 Rest of Asia-Pacific: Neoantigens Market, by Therapeutic Application - Revenue and Forecast to 2028 (USD Thousand)
  • 9.4 Middle East and Africa: Neoantigens Market
    • 9.4.1 Overview
    • 9.4.2 Middle East and Africa: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
    • 9.4.3 Middle East and Africa: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
    • 9.4.4 Middle East and Africa: Equipment Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
    • 9.4.5 Middle East and Africa: Neoantigens Market, by Country, 2020& 2028 (%)
    • 9.4.6 UAE: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.4.6.1 UAE: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.4.6.2 UAE: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.4.6.3 UAE: Equipment Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
    • 9.4.7 Saudi Arabia: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.4.7.1 Saudi Arabia: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.4.7.2 Saudi Arabia: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.4.7.3 Saudi Arabia: Equipment Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
    • 9.4.8 South Africa: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.4.8.1 South Africa: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.4.8.2 South Africa: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.4.8.3 South Africa: Neoantigens Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
    • 9.4.9 Rest of Middle East and Africa: Neoantigens Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 9.4.9.1 Rest of Middle East and Africa: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.4.9.2 Rest of Middle East and Africa Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.4.9.3 Rest of Middle East and Africa: Neoantigens Market, by Therapeutic Specialty, 2023-2028 (USD Thousand)
  • 9.5 South and Central America: Neoantigens Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Neoantigens Market, by Country, 2023 & 2028 (%)
    • 9.5.3 South and Central America: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
    • 9.5.4 South and Central America: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)
    • 9.5.5 South and Central America: Neoantigens Market, by Country, 2023 & 2028 (%)
    • 9.5.6 Brazil: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.5.6.1 Brazil: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.5.6.2 Brazil: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.5.6.3 Brazil: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)
    • 9.5.7 Argentina: Neoantigens Market - Revenue and Forecast to 2027 (USD Thousand)
      • 9.5.7.1 Argentina: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.5.7.2 Argentina: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.5.7.3 Argentina: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)
    • 9.5.8 Rest of South and Central America: Neoantigens Market - Revenue and Forecast to 2027 (USD Thousand)
      • 9.5.8.1 Rest of South and Central America: Neoantigens Market - Revenue and Forecast to 2028 (USD Thousand)
      • 9.5.8.2 Rest of South and Central America: Neoantigens Market, by Treatment, 2023-2028 (USD Thousand)
      • 9.5.8.3 Rest of South and Central America: Neoantigens Market, by Therapeutic Application, 2023-2028 (USD Thousand)

10. Impact Of COVID-19 Pandemic on Global Neoantigens Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Neoantigens Market-Industry Landscape

12. Company Profiles

  • 12.1 Achilles Therapeutics plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Advaxis, Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Frame Cancer Therapeutics
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Genocea
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Gradalis, Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Gritstone Oncology
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Immunicum AB
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medigene AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Ziopharm Oncology, Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Moderna, Inc.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms
Back to Top
전화 문의
F A Q